title: Toxic encephalopathy after exposure to azacitidine.
authors.affiliation: Hematology Division.
authors.forename: Ken
authors.initials: K
authors.lastname: Watanabe
authors.forename: Noriko
authors.initials: N
authors.lastname: Doki
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Miura
authors.forename: Takeshi
authors.initials: T
authors.lastname: Hagino
authors.forename: Shuhei
authors.initials: S
authors.lastname: Kurosawa
authors.forename: Yutaro
authors.initials: Y
authors.lastname: Hino
authors.forename: Naoki
authors.initials: N
authors.lastname: Shingai
authors.forename: Kosuke
authors.initials: K
authors.lastname: Yoshioka
authors.forename: Shinya
authors.initials: S
authors.lastname: Ishida
authors.forename: Aiko
authors.initials: A
authors.lastname: Igarashi
authors.forename: Yuho
authors.initials: Y
authors.lastname: Najima
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Kakihana
authors.forename: Hisashi
authors.initials: H
authors.lastname: Sakamaki
authors.forename: Kazuteru
authors.initials: K
authors.lastname: Ohashi
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001374:Azacitidine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000209:etiology*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine